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Introduction
DNA double-strand breaks (DSBs) are dangerous lesions that 
threaten genomic integrity, and it is critically important for cells 
to detect and properly repair them to maintain genome stability 
(Jackson and Bartek, 2009). Cells are equipped with a DNA dam-
age response (DDR) to detect and correct these lesions (Ciccia 
and Elledge, 2010). This response includes the cell cycle check-
points that induce cell cycle arrest in G1 and G2 phases as well as 
slowing down of DNA synthesis (Iliakis et al., 2003). Check-
points allow time for DSB repair, which is mediated by either 
homologous recombination (HR) or nonhomologous end joining 
(NHEJ; Iliakis et al., 2003; Jackson and Bartek, 2009).
There are major differences in the two DSB repair path-
ways, which are manifested already at the initial DNA end pro-
cessing stage. Whereas NHEJ only requires little end processing, 
HR requires the removal of up to several hundred bases of the 
5 strand to generate a long 3 single-stranded DNA (ssDNA) 
tail through the process of DNA end resection (Huertas, 2010; 
Mimitou and Symington, 2011). This tail is subsequently cov-
ered with RAD51, forming the structure that searches for the 
homologous sequence in the sister chromatid (Moynahan and 
Jasin, 2010). The mechanism and regulation of end resection of 
DSBs are not fully understood, although it requires the activity 
of several nucleases and helicases (Gravel et al., 2008; Huertas, 
2010; Mimitou and Symington, 2011). The MRN (MRE11–
RAD50–NBS1) complex may carry out the initial stage of DNA 
end processing by removing a few nucleotides of the 3 strand 
DNA from a DSB end (Huertas, 2010; Mimitou and Symington, 
2011). The CtIP protein also plays an important role in HR 
repair through regulation of DNA end resection (Sartori et al., 
2007). CtIP is recruited to sites of DNA damage, where it is 
thought to cooperate with the MRN complex (Sartori et al., 
2007). The exonuclease activity of MRE11 has 3–5 direction-
ality, whereas generation of the resected overhang requires 
5–3 resection, which suggests the action of other nucleases 
such as EXO1 and DNA2 exonucleases, which are capable of 
generating 3 ssDNA overhangs (Eid et al., 2010; Huertas, 
2010; Mimitou and Symington, 2011). The ssDNA generated 
from the resection process is immediately coated by replication 
protein A (RPA), which promotes both checkpoint activation 
and HR repair (Cimprich and Cortez, 2008; Huertas, 2010).
To prevent accumulation of mutations, cells respond to DNA lesions by blocking cell cycle progression and initiating DNA repair. Homology-directed repair 
of DNA breaks requires CtIP-dependent resection of the 
DNA ends, which is thought to play a key role in acti-
vation of ATR (ataxia telangiectasia mutated and Rad3 
related) and CHK1 kinases to induce the cell cycle check-
point. In this paper, we show that CHK1 was rapidly 
and robustly activated before detectable end resection. 
Moreover, we show that the key resection factor CtIP was 
dispensable for initial ATR–CHK1 activation after DNA 
damage by camptothecin and ionizing radiation. In con-
trast, we find that DNA end resection was critically re-
quired for sustained ATR–CHK1 checkpoint signaling and 
for maintaining both the intra–S- and G2-phase check-
points. Consequently, resection-deficient cells entered 
mitosis with persistent DNA damage. In conclusion, we have 
uncovered a temporal program of checkpoint activation, 
where CtIP-dependent DNA end resection is required for 
sustained checkpoint signaling.
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was confirmed in a primary cell line (Fig. S1 A). We also 
noted a significant increase in the level of CHK1 phosphory-
lation at later time points in CPT-treated cells that coincided 
with the initiation of DNA end resection, indicating a func-
tional relation (Fig. 1 A).
Initial ATR–CHK1 activation occurs 
independently of DNA end resection
CtIP is a critical factor in DNA end resection after DNA 
damage (Sartori et al., 2007). Given the temporal separation 
of ATR–CHK1 activation and extensive end resection, we ad-
dressed whether abrogation of resection would have an impact 
on activation of ATR/CHK1. We found that the ATR–CHK1 
pathway was activated rapidly after CPT treatment in CtIP-
 depleted cells. This was apparent at the earliest time point, as 
measured by increased CHK1 phosphorylation and CDC25A 
decrease (Fig. 1 C). Notably, when looking at time points after 
the onset of extensive DNA end resection, we found that the 
level of phosphorylated CHK1 was substantially reduced in 
CtIP-depleted cells compared with mock-depleted cells (Figs. 1 
C and S1 B). To test whether the initial CHK1 phosphorylation 
was dependent on ATR activity, we depleted cells for the key 
ATR activator TopBP1. In response to CPT treatment, we found 
that depletion of TopBP1 led to a complete abrogation of CHK1 
but not CHK2 phosphorylation (Fig. 1 C). We subsequently ad-
dressed whether the observed increase in CHK1 phosphorylation 
at later time points was indeed dependent on resected DNA ends. 
To investigate this, we used a low concentration of CPT (0.1 µM) 
that leads to little DNA breakage (Ray Chaudhuri et al., 2012) 
and consequently limited resection, as measured by RPA hyper-
phosphorylation. ATR–CHK1 activation was unaffected by CtIP 
depletion at low-dose CPT (Fig. 1 D), supporting the notion that 
the increase in ATR–CHK1 activity was caused by extensive 
DNA resection.
CPT induces DNA DSB damage specifically at the repli-
cation fork. To corroborate our findings, we treated cells with 
ionizing radiation (IR), which results in stochastic replication-
independent DNA damage (DSBs). As was the case for CPT-
treated cells, initial activation of ATR–CHK1 and CDC25A 
degradation appeared largely independent of CtIP upon IR 
(Figs. 2 A and S1 C). However, CtIP was required to support 
CHK1 phosphorylation at later time points. In line with this, 
CDC25A reappeared prematurely in CtIP-depleted cells, indica-
tive of insufficient ATR–CHK1 activity and defective checkpoint 
maintenance. Furthermore, the initial CHK1 phosphorylation 
was abolished by TopBP1 depletion, indicating that CHK1 is 
targeted by ATR-mediated phosphorylation after IR (Fig. 2 A). 
We found that DNA end resection was apparent at 45 min 
after irradiation, as observed by both RPA foci formation 
(Fig. 2 B) and by immunostaining for ssDNA (Fig. S1 D). A large 
part of CHK1 signaling in asynchronously growing cells is origi-
nating from S-phase cells. To understand whether G2-phase 
cells share the same regulation, we measured IR-induced check-
point responses in synchronized cells (Fig. S1 E). We found that 
CtIP is dispensable for initial CHK1 activation but is required 
for sustained CHK1 phosphorylation (Fig. 2 C). These findings 
are in agreement with our findings for CPT-treated cells.
A key feature of the DDR is the activation of the PI3-
kinase–related protein kinases ataxia telangiectasia mutated 
(ATM), ATR (ATM and Rad3 related), and DNA–protein 
kinase, which target a large number of substrates to regulate the 
cellular responses to DNA damage, including checkpoint acti-
vation (Ciccia and Elledge, 2010). A critical target of the check-
point signaling cascade is CHK1 kinase, which is required for 
the S- and G2-phase checkpoints in mammalian cells (Zhao 
et al., 2002; Sørensen et al., 2003). CHK1 restrains the activity 
of the CDC25A phosphatase, an activator of the Cdks, through 
phosphorylation-dependent ubiquitylation and degradation 
(Busino et al., 2004). CHK1 activity is regulated by ATR phos-
phorylation on S317 and S345 (Cimprich and Cortez, 2008). 
ATR is constitutively associated with ATR-interacting protein, 
which binds directly to RPA-coated ssDNA (Cortez et al., 
2001), which can be generated by nuclease- and helicase- 
dependent processing of DNA (Cimprich and Cortez, 2008). The 
junctions between ssDNA and double-stranded DNA are also 
important for ATR activation, likely by recruiting the ATR-
activating factor TopBP1 (Kumagai et al., 2006; Cimprich 
and Cortez, 2008). Importantly, end resection during HR gener-
ates both ssDNA and junctions between single and double 
strands, which has led to the model that resection is critical 
for ATR/CHK1 activation (You and Bailis, 2010).
Here, we have investigated the interplay between DNA 
end resection and checkpoint responses. We now show that the 
CHK1-mediated checkpoint response is activated rapidly after 
DSB induction in a manner independent of resection by CtIP, 
EXO1, and DNA2. Importantly, resection is crucial for check-
point maintenance, thereby linking DNA processing with pro-
longed cell cycle arrest to allow sufficient time for DNA repair.
Results and discussion
Checkpoint activation and DNA end 
resection are temporally separated
The interplay between DNA repair and checkpoint signaling is 
not fully understood. To address this, we treated U2OS cells 
with the DNA topoisomerase I poison camptothecin (CPT), 
which generates DSBs during DNA replication. Activation of 
checkpoint pathways measured by CHK1 and CHK2 phosphor-
ylation was relatively rapid and detectable within minutes after 
CPT addition (Fig. 1 A). The CHK1 target CDC25A was also 
found to be rapidly degraded, indicative of checkpoint activa-
tion. In contrast, we found that RPA2 phosphorylation, which 
has been used as a readout for DNA end resection (Bunting 
et al., 2010), was delayed and not detectable until 40 min after 
CPT addition (Fig. 1 A). To investigate this further, we moni-
tored the timing of DNA end resection by observing the occur-
rence of ssDNA after CPT treatment (Fig. 1 B). The formation 
of ssDNA was apparent 30–40 min after drug addition, which 
supported the finding that DNA end resection occurs consider-
ably later than checkpoint activation. Interestingly, this indi-
cated that DNA end resection, which is critical for the initiation 
of HR-mediated repair, might play a limited role in the initial 
activation of the ATR–CHK1 pathway. Moreover, the temporal 
separation of ATR–CHK1 activation and RPA phosphorylation 
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comparable with that of the control-depleted cells. However, 
at later time points, there was a dramatic increase in the per-
centage of mitotic cells in spite of irradiation, indicating a 
critical role for CtIP in checkpoint maintenance (Fig. 3 A). 
Similar data were observed when G2-phase–synchronized cells 
were analyzed (Fig. S2 B). As expected, CHK1 was required 
for the early and late phases of the G2/M checkpoint (Fig. S2 C). 
Similar temporal dependency on CtIP was observed for the 
intra–S-phase checkpoint. Initially, DNA replication was reduced 
Maintenance of the G2/M- and S-phase 
checkpoints is dependent on CtIP
Having established that CtIP has a temporally distinct impact 
on CHK1 activity, we next investigated the role of CtIP in cell 
cycle checkpoints. In response to irradiation of control siRNA–
depleted cells, the fraction of mitotic cells was significantly 
reduced both at relatively early and late time points (Fig. 3 A). 
Interestingly, CtIP-depleted cells did initially activate the check-
point, as indicated by a significant decrease in mitotic cells, 
Figure 1. Checkpoint initiation and CtIP-dependent DNA end resection are temporally separated. (A) U2OS cells were either left untreated or treated with 
1 µM CPT for the indicated time. Cells were harvested and processed for immunoblotting with the indicated antibodies. (B) U2OS cells were seeded on 
coverslips and incubated with BrdU for 24 h. Cells were treated with 1 µM CPT for the indicated time, fixed, and stained with BrdU and 53BP1 antibodies 
under native conditions. Pictures were acquired using epifluorescence microscopy. Bar, 10 µm. (C) U2OS cells were transfected for 2 d with the indicated 
siRNAs. Cells were treated with 1 µM CPT for the indicated time and then processed as in A. Numbers represent quantification of phosphorylated CHK1. 
siUNC, Universal Negative Control siRNA. (D) U2OS cells were transfected for 2 d with the indicated siRNAs. The cells were treated with 0.1 µM or 1 µM 
CPT and then processed as in A. Numbers are as in C.
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that irradiated cells devoid of CtIP showed a marked presence 
of H2AX foci in mitosis (Fig. 3 C). Because of the fact that 
control-depleted cells do not enter mitosis before all damage 
has been repaired, we quantified the amount of mitotic cells 
with H2AX foci 18 h after irradiation. Even at this late time 
point, CtIP-depleted mitotic cells had a significant amount of 
persisting H2AX foci, whereas mock-depleted cells had almost 
no H2AX foci (Figs. 3 D and S2 D). These findings clearly indi-
cate that CtIP-depleted cells enter mitosis with unrepaired lesions 
after IR treatment.
Extensive DNA end resection is critical for 
checkpoint maintenance
CtIP is functionally involved in additional cellular processes, 
such as transcriptional control, that could affect DDRs (Wu and 
Lee, 2006). To further address the role of CtIP in checkpoint 
maintenance, we made use of cell lines stably expressing a 
T847A mutant and a C-terminal truncated version of RNAi-
resistant CtIP (Fig. 4 B). These mutants are resection deficient 
(Sartori et al., 2007; Huertas and Jackson, 2009), and the cor-
responding cell lines were unable to resect DNA (Fig. S3 A 
in CtIP-depleted cells to a level indistinguishable from control-
depleted cells. However, at later time points, DNA replica-
tion was substantially elevated in CtIP-depleted cells relative 
to the control cells (Fig. 3 B). To rule out off-target effects 
of the siRNA depletions, we performed reconstitution exper-
iments using an U2OS cell line stably expressing an siRNA-
insensitive GFP-CtIP allele. Importantly, both the G2/M- and 
intra–S-phase DNA damage checkpoint defects caused by 
CtIP down-regulation were rescued using this cell line (Fig. 3, 
A and B). In addition, CtIP depletion had only little effect on 
cell cycle progression, ruling out cell cycle defects as an expla-
nation for the phenotypes (Fig. S2 A).
It was previously shown that the activity of CtIP restricts 
repair by NHEJ (Yun and Hiom, 2009). Thus, a potential expla-
nation of the observed defects in checkpoint maintenance could 
be that the faster NHEJ pathway substitutes for the slower HR 
pathway in CtIP-depleted cells. In theory, this could result in 
faster repair kinetics and therefore mimic premature termina-
tion of the checkpoint response (Shibata et al., 2011). To test 
this, we investigated whether all DNA damage had indeed been 
repaired before mitotic entry in CtIP-depleted cells. We found 
Figure 2. CtIP-dependent DNA end resection 
is required for sustained checkpoint signaling. 
(A) U2OS cells were transfected for 2 d using 
the indicated siRNAs. Cells were irradiated 
(10 Gy), collected at the indicated time points, 
and processed as in Fig. 1 A. Numbers are 
as in Fig. 1 C. siUNC, Universal Negative 
Control siRNA. (B) U2OS cells were seeded 
on coverslips and siRNA transfected for 2 d. 
After IR, cells were fixed at the indicated times 
and stained for RPA and H2AX. Pictures 
were acquired using confocal microscopy. 
Bar, 10 µm. (C) U2OS cells were transfected 
with control or CtIP siRNA and synchronized 
in G2 phase by double thymidine treatment. 
Cells were irradiated (15 Gy), collected at the 
indicated time points, and then processed for 
immunoblotting with the indicated antibodies. 
Numbers are as in Fig. 1 C. AS, asynchro-
nized growing cells.
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maintenance when inhibition occurred after initiation of re-
section. In contrast to this, inhibition of CHK1 both before 
and after initiation of resection almost completely abrogated 
the G2/M checkpoint (Fig. 4 C). This indicates that ATM 
mainly contributes to G2/M checkpoint maintenance through 
resection-dependent activation of ATR/CHK1.
CtIP has been shown to promote resection by supporting 
the activation of DNA nucleases (Mimitou and Symington, 
2011). We reasoned that such nucleases operating downstream 
of CtIP could also participate in regulating G2/M checkpoint 
maintenance. To address this, we depleted cells of EXO1 and 
DNA2, two nucleases that are important exonucleases in the 
resection process (Nimonkar et al., 2011). Both nucleases were 
and not depicted). Whereas wild-type CtIP restored checkpoint 
function, the two mutant versions were unable to do so (Fig. 4 A), 
indicating that the resection activity of CtIP is responsible 
for checkpoint maintenance. ATM kinase has previously been 
shown to be required for resection of DSBs as well as regulation 
of the cell cycle checkpoint (Iliakis et al., 2003; Jazayeri et al., 
2006). To test the temporal role of ATM in the G2/M check-
point, we used a specific inhibitor (Hickson et al., 2004). As ex-
pected, we found that inhibition of ATM completely abolished 
ATM autophosphorylation, CtIP phosphorylation, and resec-
tion after IR (Fig. S3 B). Also, inhibition of ATM abolished the 
G2/M checkpoint to a similar extent as depletion of CtIP. Inter-
estingly, we found that ATM was dispensable for checkpoint 
Figure 3. CtIP is critical for IR-induced checkpoint maintenance. (A) U2OS cells or U2OS cells stably expressing siRNA-resistant GFP-CtIP were transfected 
with the indicated siRNA for 2 d, and samples were fixed at the indicated time points after IR. Nocodazole (Noco) was added 2 h after IR. The bar chart 
shows the percentage of Histone H3-Ser10p–positive cells measured by flow cytometry. Data are the means of three independent experiments. Error bars 
represent SDs. The inset blot shows expression levels of GFP-CtIP and endogenous (endo) CtIP in the used cells lines. siUNC, Universal Negative Control 
siRNA. (B) RDS assay was performed using U2OS cells or U2OS cells stably expressing siRNA-resistant GFP-CtIP. Cells were siRNA transfected for 2 d with 
the indicated siRNAs and subjected to RDS assay. Data are the means of three independent experiments. Error bars represent SDs. (C) U2OS cells were 
seeded on coverslips and transfected for 2 d with the indicated siRNAs. The samples were treated with IR and nocodazole, as indicated, followed by fixa-
tion. Cells were stained for Histone H3-S10p and H2AX, and images were acquired using epifluorescence microscopy. Bar, 10 µm. (D) U2OS cells were 
treated as in Fig. S2 D. The bar chart shows the percentage of Histone H3-S10p–positive cells with more than five H2AX foci for a given treatment. Data 
are the means of three independent experiments. For each sample, at least 50 Histone H3-S10p–positive cells were counted. Error bars represent SDs.
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generated at the newly formed DSBs could activate the ATR 
pathway (MacDougall et al., 2007). These junctions may 
provide a loading site for the RAD9–RAD1–HUS1 complex 
during S and G2 phases, thereby recruiting TopBP1 to activate 
ATR (Kumagai et al., 2006; Cimprich and Cortez, 2008).
CtIP has previously been implicated in regulation of the 
G2/M checkpoint; however, the authors suggested a role for 
CtIP in early but not late stages of the checkpoint (Yu and Chen, 
2004). The observed discrepancy may relate to the different ex-
perimental setups, as the authors relied on immunofluorescence 
to score checkpoint status. In addition to its role in G2/M check-
point maintenance, we discovered that CtIP-deficient cells are 
defective in late stages of the S-phase checkpoint. A previous 
study found no role of CtIP in this checkpoint (Greenberg et al., 
2006). However, the authors investigated one time point 30 min 
after IR, which is at an early stage that precedes DNA end resec-
tion. Premature initiation of DNA replication using a damaged 
template could lead to loss of genomic integrity. In this regard, it 
is noteworthy that CtIP is a haploinsufficient tumor suppressor in 
the mouse (Chen et al., 2005).
Materials and methods
Cell culture, chemicals, and siRNA
Human U2OS osteosarcoma and Tig3 TERT cell lines were grown in 
DME medium with 10% FBS. U20S cell lines stably expressing siRNA-
resistant N-terminally EGFP-tagged CtIP pEGFP-C1 vector were selected 
with G418 (0.5 mg/ml) and tested for expression (by immunofluorescence 
dispensable for checkpoint activation but were required for effi-
cient checkpoint maintenance (Fig. 4 D). However, the role of 
the nucleases was less pronounced than CtIP. Depletion of 
DNA2 and EXO1 did not affect cell cycle progression, as cells 
progressed well into mitosis in the absence of IR (Fig. S3 C). 
Both nucleases were efficiently depleted, and their individual 
depletion led to some decrease in resection, as measured by 
RPA2 hyperphosphorylation, although, again, not as marked as 
CtIP depletion (Fig. S3 D). Codepletion experiments targeting 
both DNA2 and EXO1 were not possible as a result of marked 
cell cycle progression issues and occurrence of spontaneous 
DNA damage (unpublished data).
It has previously been demonstrated that the initial 
checkpoint response in S and G2 phase is dependent on CHK1 
kinase, which inhibits CDC25 phosphatases (Zhao et al., 2002; 
Sørensen et al., 2003). Here, we show that this pathway operates 
before extensive DNA end resection, thus facilitating a rapid 
inhibition of DNA replication and mitotic entry of cells with 
damaged DNA (Fig. 4 E). Once HR repair is initiated, the CtIP-
dependent checkpoint pathway then ensures sufficient time for 
repair by restraining mitotic entry until the repair process is 
complete. The rapid CHK1 activation could be through MRN 
complex–dependent loading of TopBP1 at the break site (Yoo 
et al., 2009). This pathway is strongly stimulated by ATM-
mediated phosphorylation of TopBP1, and it can explain the role 
of ATM, TopBP1, and ATR in a resection-independent check-
point pathway. It is also possible that short ssDNA junctions 
Figure 4. Checkpoint maintenance is dependent on 
DNA end resection. (A) U2OS cells or U2OS cells 
stably expressing siRNA-resistant GFP-CtIP were trans-
fected with the indicated siRNA for 2 d. Samples were 
fixed 8 h after IR and 6 h after nocodazole addition 
and then processed as in Fig. 3 A. For each sample, 
the H3Ser10p value was divided by the correspond-
ing nocodazole (Noco) control to normalize for mi-
totic entry in the absence of IR. Data are the means of 
three independent experiments. Error bars represent 
SDs. WT, wild type. (B) U2OS cells or U2OS cells 
stably expressing siRNA-resistant GFP-CtIP were trans-
fected for 2 d using the indicated siRNAs. The cells 
were harvested and processed for immunoblotting 
using the indicated antibodies. endo, endogenous. 
(C) U2OS cells were treated with DMSO or the ATM 
inhibitor (ATMi) 30 min before or 1 h after IR (5 Gy), 
as indicated. Nocodazole was applied 1.5 h after 
IR, and samples were fixed 6 h after IR. The bar chart 
shows the percentage of Histone H3-S10p–positive 
cells measured by flow cytometry and calculated as in 
A. Data are the means of three independent experi-
ments. Error bars represent SDs. (D) U2OS cells were 
transfected with the indicated siRNA for 2 d, and sam-
ples were fixed at the indicated time points after IR and 
then processed as in A. Data are the means of three 
independent experiments. Error bars represent SDs. 
siUNC, Universal Negative Control siRNA. (E) Illustration 
of resection-independent checkpoint activation followed 
by resection-dependent maintenance of the ATR–
CHK1-dependent S- and G2-phase checkpoints. Red 
circles indicate RPA. P, phosphorylation.
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and stained with antibodies toward phospho–Histone H3-S10 (1:200; 
Millipore) and -H2AX (1:1,000; Millipore) for 1 h followed by a 1-h 
incubation with Alexa Fluor 488 and 647 secondary antibodies (1:1,000; 
Invitrogen). DNA was stained using 0.1 mg/ml propidium iodide containing 
RNase for 30 min at 37°C. Flow cytometry analysis was performed on 
FACSCalibur using CellQuest Pro software (BD). Data were analyzed using 
FlowJo software (v7.2.2; Tree Star).
Radioresistant DNA synthesis (RDS) assay
The RDS assay was performed as previously described (Sørensen et al., 
2003). In brief, U2OS cells or U2OS cells stably expressing siRNA-
 resistant GFP-CtIP were transfected with siRNAs. After washing off the 
transfection, cells were incubated for 24 h with 20 nCi/ml [14C]thymidine 
(NEC156010UC; PerkinElmer) followed by another 24-h incubation in 
nonradioactive medium. Cells were either left untreated or irradiated 
(10 Gy), and [3H]thymidine (NET027A250UC; PerkinElmer) at a final 
concentration of 2.5 µCi/ml was added 15 min before fixing the cells 
in 70% methanol. The cells were washed in PBS, and radioactivity was 
measured in a liquid scintillation counter. The ratios of [3H]/[14C] were 
calculated, and DNA synthesis after irradiation was expressed as a 
percentage of nonirradiated values.
Online supplemental material
Fig. S1 shows that the temporal separation of CHK1 phosphorylation 
and DNA end resection is observed in Tig3 fibroblast cells. We also de-
tected very little DNA end resection in CtIP-depleted cells, both after IR 
and CPT treatment. CHK1 phosphorylation is not affected by CtIP deple-
tion shortly after IR was applied. Finally, we show cell cycle profiles of double 
thymidine–synchronized cells. Fig. S2 shows that G2-synchronized, CtIP-
depleted cells are not entering mitosis within the first hour after IR treat-
ment. In the absence of IR, CtIP-depleted cells and cells stably expressing 
GFP-CtIP are progressing into mitosis as mock-treated cells. Moreover, 
CHK1 is required for the G2/M checkpoint at all time points after IR treat-
ment. Representative microscope pictures of damage (H2AX) in mitotic 
cells show that the damage is persisting in CtIP-depleted cells that enter 
mitosis after IR. Fig. S3 shows that DNA end resection after either IR or 
CPT is strongly suppressed in ATM-inhibited cells, CtIP-depleted cells, and 
cells expressing C-CtIP. Also, DNA end resection is partly suppressed in 
DNA2 and Exo1-depleted cells after CPT. Finally, the siRNAs efficiently 
depleted DNA2 and Exo1 and had no observable impact on cell cycle 
progression. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201111065/DC1.
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